Intravitreal Tamponade Agents in Vitreoretinal Surgery: Current Advances and Future Directions.

IF 2.3 4区 医学 Q2 OPHTHALMOLOGY
Ophthalmologica Pub Date : 2026-01-01 Epub Date: 2026-02-12 DOI:10.1159/000550824
Marco R Pastore, Alberto Grotto, Marco Celega, Cosmin Sava, Alessandra Martina, Olimpia Colombo, Eric H Souied, Daniele Tognetto
{"title":"Intravitreal Tamponade Agents in Vitreoretinal Surgery: Current Advances and Future Directions.","authors":"Marco R Pastore, Alberto Grotto, Marco Celega, Cosmin Sava, Alessandra Martina, Olimpia Colombo, Eric H Souied, Daniele Tognetto","doi":"10.1159/000550824","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Intravitreal tamponades are essential tools in vitreoretinal surgery, widely used for the treatment of posterior segment pathologies. Conventional tamponade agents - such as intraocular gases and silicone oils - have significantly improved surgical outcomes but are associated with limitations including the need for specific postoperative positioning, intraocular pressure fluctuations, and in some cases, secondary removal procedures.</p><p><strong>Summary: </strong>This review provides a comprehensive overview of currently available intravitreal tamponade agents, highlighting their indications, physical properties, clinical applications, and complications. Special attention is given to heavy tamponades, perfluorocarbon liquids, and recent developments in tamponade strategies. The article also explores future directions, including drug-eluting tamponades and the development of synthetic vitreous substitutes that aim to mimic the native vitreous body and reduce the need for postoperative interventions.</p><p><strong>Key message: </strong>While current tamponade agents remain indispensable in vitreoretinal surgery, ongoing research into smarter, safer, and more physiologically compatible materials holds great promise. Future tamponades may not only offer mechanical support but also actively contribute to retinal healing and pharmacologic delivery, potentially transforming the standard of care in retinal surgery.</p>","PeriodicalId":19595,"journal":{"name":"Ophthalmologica","volume":" ","pages":"249-264"},"PeriodicalIF":2.3000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000550824","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Intravitreal tamponades are essential tools in vitreoretinal surgery, widely used for the treatment of posterior segment pathologies. Conventional tamponade agents - such as intraocular gases and silicone oils - have significantly improved surgical outcomes but are associated with limitations including the need for specific postoperative positioning, intraocular pressure fluctuations, and in some cases, secondary removal procedures.

Summary: This review provides a comprehensive overview of currently available intravitreal tamponade agents, highlighting their indications, physical properties, clinical applications, and complications. Special attention is given to heavy tamponades, perfluorocarbon liquids, and recent developments in tamponade strategies. The article also explores future directions, including drug-eluting tamponades and the development of synthetic vitreous substitutes that aim to mimic the native vitreous body and reduce the need for postoperative interventions.

Key message: While current tamponade agents remain indispensable in vitreoretinal surgery, ongoing research into smarter, safer, and more physiologically compatible materials holds great promise. Future tamponades may not only offer mechanical support but also actively contribute to retinal healing and pharmacologic delivery, potentially transforming the standard of care in retinal surgery.

玻璃体内填塞剂在玻璃体视网膜手术中的应用:当前进展和未来方向。
背景:玻璃体内填塞是玻璃体视网膜手术中必不可少的工具,广泛用于治疗后段病变。传统的填塞剂——如眼内气体和硅油——可以显著改善手术效果,但也存在局限性,包括需要特定的术后定位、眼压波动,在某些情况下,还需要二次移除手术。摘要:本文综述了目前可用的玻璃体内填塞剂,重点介绍了它们的适应症、物理特性、临床应用和并发症。特别注意重型填塞、全氟碳液体和填塞战略的最新发展。文章还探讨了未来的发展方向,包括药物洗脱填塞和人工合成玻璃体替代品的发展,旨在模仿天然玻璃体,减少术后干预的需要。关键信息:虽然目前的填塞剂在玻璃体视网膜手术中仍然是必不可少的,但正在进行的对更智能、更安全、更生理相容材料的研究具有很大的前景。未来的填塞不仅可以提供机械支持,还可以积极促进视网膜愈合和药物输送,有可能改变视网膜手术的护理标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ophthalmologica
Ophthalmologica 医学-眼科学
CiteScore
5.10
自引率
3.80%
发文量
39
审稿时长
3 months
期刊介绍: Published since 1899, ''Ophthalmologica'' has become a frequently cited guide to international work in clinical and experimental ophthalmology. It contains a selection of patient-oriented contributions covering the etiology of eye diseases, diagnostic techniques, and advances in medical and surgical treatment. Straightforward, factual reporting provides both interesting and useful reading. In addition to original papers, ''Ophthalmologica'' features regularly timely reviews in an effort to keep the reader well informed and updated. The large international circulation of this journal reflects its importance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书